Vitamin D-binding protein

GC
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesGC, DBP, DBP/GRD3, HEL-S-51, VDBG, VDBP, Gc-MAF, GcMAF, vitamin D binding protein, DBP-maf, VDB, GC vitamin D binding protein
External IDsOMIM: 139200; MGI: 95669; HomoloGene: 486; GeneCards: GC; OMA:GC - orthologs
Orthologs
SpeciesHumanMouse
Entrez

2638

14473

Ensembl

ENSG00000145321

ENSMUSG00000035540

UniProt

P02774

P21614

RefSeq (mRNA)

NM_000583
NM_001204306
NM_001204307

NM_008096

RefSeq (protein)

NP_000574
NP_001191235
NP_001191236

NP_032122

Location (UCSC)Chr 4: 71.74 – 71.8 MbChr 5: 89.57 – 89.61 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Vitamin D-binding protein (DBP), also/originally known as gc-globulin (group-specific component), is a protein that in humans is encoded by the GC gene.[5][6] DBP is genetically the oldest member of the albuminoid family and appeared early in the evolution of vertebrates.[7]

Structure

Human GC is a glycosylated alpha-globulin, ~58 kDa in size. Its 458 amino acids are coded for by 1690 nucleotides on chromosome 4 (4q11–q13). The primary structure contains 28 cysteine residues forming multiple disulfide bonds. GC contains 3 domains. Domain 1 is composed of 10 alpha helices, domain 2 of 9, and domain 3 of 4.[8]

Function

Vitamin D-binding protein belongs to the albumin gene family, together with human serum albumin and alpha-fetoprotein. It is a multifunctional protein found in plasma, ascitic fluid, cerebrospinal fluid and on the surface of many cell types.

It is able to bind the various forms of vitamin D including ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3), the 25-hydroxylated forms (calcifediol), and the active hormonal product, 1,25-dihydroxyvitamin D (calcitriol). The major proportion of vitamin D in blood is bound to this protein. It transports vitamin D metabolites between skin, liver and kidney, and then on to the various target tissues.[6][9]

Beyond acting as the carrier protein for vitamin D and its metabolites, DBP also transports free fatty acids,[10] binds to actin[11] and may help prevent actin polymerization during tissue injury.[12] It also might serve as a macrophage activator, contributing to the inflammatory response by modulating T-cell activity.[13]

As Gc protein-derived macrophage activating factor it is a Macrophage Activating Factor (MAF) that has been tested for use as a cancer treatment that would activate macrophages against cancer cells.[14]

Interactive pathway map

Click on genes, proteins and metabolites below to link to respective articles. [§ 1]

[[File:
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
[[
]]
|alt=Vitamin D Synthesis Pathway (view / edit)]]
Vitamin D Synthesis Pathway (view / edit)
  1. ^ The interactive pathway map can be edited at WikiPathways: "VitaminDSynthesis_WP1531".

Production

It is synthesized by hepatic parenchymal cells and secreted into the blood circulation.[9]

Regulation

The transcription factors HFN1α is a positive regulator while HFN1β is a dominant negative regulator of DBP expression.[15]

Variation

Many genetic variants of the GC gene are known. They produce 6 main haplotypes and 3 main protein variants (Gc1S, Gc1F and Gc2).[16] The genetic variations are associated with differences in circulating 25-hydroxyvitamin D levels.[17] They have been proposed to account for some of the differences in vitamin D status in different ethnic groups,[18] and have been found to correlate with the response to vitamin D supplementation.[16]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000145321Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000035540Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Mikkelsen M, Jacobsen P, Henningsen K (Jul 1977). "Possible localization of Gc-System on chromosome 4. Loss of long arm 4 material associated with father-child incompatibility within the Gc-System". Human Heredity. 27 (2): 105–7. doi:10.1159/000152857. PMID 558959.
  6. ^ a b "Entrez Gene: GC group-specific component (vitamin D binding protein)".
  7. ^ Bouillon, R.; Schuit, F.; Antonio, L.; Rastinejad, F. (2020). "Vitamin D Binding Protein: A Historic Overview". Frontiers in Endocrinology. 10: 910. doi:10.3389/fendo.2019.00910. PMC 6965021. PMID 31998239.
  8. ^ Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C (February 2002). "A structural basis for the unique binding features of the human vitamin D-binding protein". Nature Structural Biology. 9 (2): 131–6. doi:10.1038/nsb754. PMID 11799400. S2CID 38990672.
  9. ^ a b Norman AW (August 2008). "From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health". The American Journal of Clinical Nutrition. 88 (2): 491S – 499S. doi:10.1093/ajcn/88.2.491S. PMID 18689389.
  10. ^ Williams, Merfyn H.; Van Alstyne, Eldwin L.; Galbraith, Robert M. (1988). "Evidence of a novel association of unsaturated fatty acids with Gc (Vitamin D-binding protein)". Biochemical and Biophysical Research Communications. 153 (3): 1019–1024. doi:10.1016/S0006-291X(88)81330-5.
  11. ^ Van Baelen, H.; Bouillon, R.; De Moor, P. (1980). "Vitamin D-binding protein (Gc-globulin) binds actin". Journal of Biological Chemistry. 255 (6): 2270–2272. doi:10.1016/S0021-9258(19)85885-4.
  12. ^ Meier, Ursula; Gressner, Olav; Lammert, Frank; Gressner, Axel M (2006-07-01). "Gc-Globulin: Roles in Response to Injury". Clinical Chemistry. 52 (7): 1247–1253. doi:10.1373/clinchem.2005.065680. ISSN 0009-9147.
  13. ^ Delanghe, Joris R.; Speeckaert, Reinhart; Speeckaert, Marijn M. (2015). "Behind the scenes of vitamin D binding protein: More than vitamin D binding". Best Practice & Research Clinical Endocrinology & Metabolism. 29 (5): 773–786. doi:10.1016/j.beem.2015.06.006.
  14. ^ Yamamoto N, Suyama H, Yamamoto N (July 2008). "Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF" ([PDF]). Translational Oncology. 1 (2): 65–72. doi:10.1593/tlo.08106. PMC 2510818. PMID 18633461.
  15. ^ Bouillon R, Schuit F, Antonio L, Rastinejad F (2019). "Vitamin D Binding Protein: A Historic Overview". Frontiers in Endocrinology. 10: 910. doi:10.3389/fendo.2019.00910. PMC 6965021. PMID 31998239.
  16. ^ a b Malik S, Fu L, Juras DJ, Karmali M, Wong BY, Gozdzik A, Cole DE (January–February 2013). "Common variants of the vitamin D binding protein gene and adverse health outcomes". Critical Reviews in Clinical Laboratory Sciences. 50 (1): 1–22. doi:10.3109/10408363.2012.750262. PMC 3613945. PMID 23427793.
  17. ^ McGrath JJ, Saha S, Burne TH, Eyles DW (July 2010). "A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations". The Journal of Steroid Biochemistry and Molecular Biology. 121 (1–2): 471–7. doi:10.1016/j.jsbmb.2010.03.073. PMID 20363324. S2CID 20057294.
  18. ^ Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R (November 2013). "Vitamin D-binding protein and vitamin D status of black Americans and white Americans". The New England Journal of Medicine. 369 (21): 1991–2000. doi:10.1056/NEJMoa1306357. PMC 4030388. PMID 24256378.

Further reading

  • Overview of all the structural information available in the PDB for UniProt: P02774 (Vitamin D-binding protein) at the PDBe-KB.